Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Fuller Smith & Turne a Aktie 3192856 / GB00B1YPC344

05.11.2025 19:29:15

Fuller, Smith & Turner PLC: Director / PDMR Shareholding

Fuller, Smith & Turner PLC (FSTA)
Fuller, Smith & Turner PLC: Director / PDMR Shareholding

05-Nov-2025 / 18:29 GMT/BST


 

Fuller, Smith & Turner P.L.C. (“the Company”)

Director / PDMR Shareholding

 

 

The Company announces that on 3 November 2025, the following persons discharging managerial responsibilities (“PDMR”) have exercised options to subscribe for “A” Ordinary Shares under the Company’s Savings Related Share Option Scheme 2015 at an Option Price of £4.35 per share. 

 

Name

Position

No of “A” Ordinary Shares of 40p each

Simon Emeny

Executive Chairman

6,896

Frederick Turner

Chief Operating Officer

6,896

Peter Turner

Property Director

6,896

 

The shares resulting from the exercise were transferred from the Company’s Treasury Shares account.

 

Simultaneously, Frederick Turner, sold his resulting 6,896 “A” Ordinary Shares at a price of £6.16 per share.

 

Further information is detailed in the following PDMR dealing notifications.

 

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

 

Enquiries to:

 

Rachel Spencer

Company Secretary

020 8996 2073

 

5 November 2025

 

 

 

 

 

 

 

Fuller, Smith & Turner P.L.C.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Frederick Turner

2.

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fuller, Smith & Turner P.L.C.

 

b)

LEI

213800C7ACOFMRCQQW76

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

“A” Ordinary Shares of 40p each

 

 

GB00B1YPC344

 

b)

Nature of the transaction

Exercise of 2020 5 year option granted made under the Fuller, Smith & Turner P.L.C. Savings Related Share Option Scheme 2015

c)

Price(s) and volume(s)

Price

Volume

£4.35

6,896

 

 

d)

Aggregated information

 

Aggregated volume

6,896

Price

£29,997.60

e)

Date of the transaction

3 November 2025

f)

Place of the transaction

London

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Frederick Turner

2.

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fuller, Smith & Turner P.L.C.

 

b)

LEI

213800C7ACOFMRCQQW76

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

“A” Ordinary Shares of 40p each

 

 

GB00B1YPC344

 

b)

Nature of the transaction

Sale of “A” Ordinary Shares

c)

Price(s) and volume(s)

Price

Volume

£6.16

6,896

 

 

d)

Aggregated information

 

Aggregated volume

6,896

Price

£42,479.36

e)

Date of the transaction

3 November 2025

f)

Place of the transaction

London

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Simon Emeny

2.

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fuller, Smith & Turner P.L.C.

 

b)

LEI

213800C7ACOFMRCQQW76

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

“A” Ordinary Shares of 40p each

 

 

 GB00B1YPC344

b)

Nature of the transaction

Exercise of 2020 5 year option granted made under the Fuller, Smith & Turner P.L.C. Savings Related Share Option Scheme 2015

c)

Price(s) and volume(s)

Price

Volume

£4.35

6,896

 

 

d)

Aggregated information

 

Aggregated volume

6,896

Price

£29,997.60

e)

Date of the transaction

3 November 2025

f)

Place of the transaction

London

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Peter Turner

2.

Reason for the notification

a)

Position/status

Property Director

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fuller, Smith & Turner P.L.C.

 

b)

LEI

213800C7ACOFMRCQQW76

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

“A” Ordinary Shares of 40p each

 

 

GB00B1YPC344

b)

Nature of the transaction

Exercise of 2020 5 year option granted made under the Fuller, Smith & Turner P.L.C. Savings Related Share Option Scheme 2015

c)

Price(s) and volume(s)

Price

Volume

£4.35

6,896

 

 

d)

Aggregated information

 

Aggregated volume

6,896

Price

£29,997.60

e)

Date of the transaction

3 November 2025

f)

Place of the transaction

London

 



Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


ISIN: GB00B1YPC344
Category Code: DSH
TIDM: FSTA
LEI Code: 213800C7ACOFMRCQQW76
Sequence No.: 407304
EQS News ID: 2224658

 
End of Announcement EQS News Service

Analysen zu Fuller Smith & Turner PLC (A)

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’193.40 19.16 SJ6B5U
Short 13’444.90 13.69 U2TBSU
Short 13’930.53 8.90 SY9BNU
SMI-Kurs: 12’702.08 11.11.2025 17:30:12
Long 12’163.68 19.77 SO2B2U
Long 11’889.18 13.84 SZDBEU
Long 11’379.10 8.90 SPMBUU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com